Cystic Fibrosis - Deals Analytics Report, 2010 to 2021

Published: August 11, 2021 |

GervanoRA Data Services LLP | 60 Pages | Delivery time: 3-5 business days

Price

Description
Table of Contents
List of Tables

Add to Compare

GervanoRA's 'Cystic Fibrosis Deals Activity Report, 2010-2021' has analyzed and provided an understanding of the overall competition in partnering landscape in the disease area that has occurred from the year 2010.

GervanoRA has analyzed more than 90 drug candidates in the current development pipeline. Hence, a number of emerging and clinical-stage companies are embarking with collaborations or partnerships with different pharma companies to aid in the development process of their respective drug candidates. In the light of rocketing competition, not only companies, but also universities, institutes and research centers are getting actively involved in the advancements of new medicines for the treatment of the disease.

The report through its meticulous analysis on global therapeutic landscape of Cystic Fibrosis deals assists companies in taking future partnering decisions based on competitor's R&D activities; current trends in partnering landscape in order to avoid or mitigate competitive market risks.

For a proper understanding, GervanoRA has segmented the report into sections based on:

Analytics based on deal type,
Analytics based on deal by value,
Analytics based on geography
Analytics based on deal maker
Year-by-year analytics

The report also includes case studies provided for the deals that were prominent and unique among all the deals.

Product Code: GERPD001

1. INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. METHODOLOGY
1.3. OTHER AVAILABLE DEALS ANALYSIS REPORTS
1.4. ABOUT US: GERVANORA DATA SERVICES

2. EXECUTIVE SUMMARY

3. ANALYTICS BY DEAL TYPE

3.1. CYSTIC FIBROSIS AGREEMENTS
3.2. CYSTIC FIBROSIS COLLABORATIONS
3.3. CYSTIC FIBROSIS MERGERS & ACQUISITIONS
3.4. CYSTIC FIBROSIS FINANCING- GRANT AND FUNDING DEALS
3.5. CYSTIC FIBROSIS LICENSING DEALS
3.6. CYSTIC FIBROSIS ALLIANCE DEAL

4. ANALYTICS BY DEAL VALUE AND GEOGRAPHY

5. ANALYTICS BY ACTIVE PLAYERS

6. ANALYTICS BY ANNUAL FREQUENCY

7. CASE STUDIES- TOP FIVE PROMINENT DEALS

8. ABBREVIATIONS

LIST OF TABLES

TABLE 01: MAJOR AGREEMENTS IN THE CYSTIC FIBROSIS AREA
TABLE 02: MAJOR COLLABORATIONS IN THE CYSTIC FIBROSIS AREA
TABLE 03: MAJOR COLLABORATIONS IN THE CYSTIC FIBROSIS AREA
TABLE 04: MAJOR FINANCING DEALS- GRANTS AND FUNDING IN THE CYSTIC FIBROSIS AREA
TABLE 05: MAJOR LICENSING DEALS IN THE CYSTIC FIBROSIS AREA
TABLE 06: TOP 10 MAJOR DEALS IN THE CYSTIC FIBROSIS AREA RANKED BY DEAL AMOUNT

LIST OF FIGURES

FIGURE 01: CYSTIC FIBROSIS DEALS, BY DEAL TYPE
FIGURE 02: CYSTIC FIBROSIS DEAL AMOUNT SHARE BY DEAL TYPE
FIGURE 03: CYSTIC FIBROSIS DEALS SCENARIO, YEAR V/S DEAL AMOUNT
FIGURE 04: PHARMACEUTICAL COMPANIES INVOLVED IN MORE THAN A SINGLE DEAL IN CF AREA
FIGURE 05: NUMBER OF CYSTIC FIBROSIS DEALS, YEAR BY YEAR
FIGURE 06: INCREASING AGREEMENT DEALS

License/Price